Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JD.Com Inc (JD) vs Mesoblast Limited (MESO) Price & Performance

JD.Com IncTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

JD.Com Inc vs Mesoblast Limited — how do they compare? JD.Com Inc trades at $31.45 (market cap $44.04B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: JD.Com Inc is far larger — about 19.9× Mesoblast Limited's market cap, and JD.Com Inc pays a 3.13% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.

JDMESO
Market Cap
$44.04B$2.21B
Sector
Consumer CyclicalTechnology
52-Week High
$36.17$20.96
52-Week Low
$25.19$12.88
Enterprise Value
$30.10B$2.21B
Dividend Yield
3.13%

Returns comparison

Trailing returns across standard periods

About JD.Com Inc

JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.

Read more on JD

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO